1-(5-bromo-1,2,3,4-tetrahydroquinoxalin-6-yl)-2-(4,5-dihydro-1H-imidazol-2-yl)hydrazine structure
|
Common Name | 1-(5-bromo-1,2,3,4-tetrahydroquinoxalin-6-yl)-2-(4,5-dihydro-1H-imidazol-2-yl)hydrazine | ||
|---|---|---|---|---|
| CAS Number | 134892-42-5 | Molecular Weight | 311.18100 | |
| Density | 1.84g/cm3 | Boiling Point | 420ºC at 760 mmHg | |
| Molecular Formula | C11H15BrN6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 207.8ºC | |
| Name | 1-(5-bromo-1,2,3,4-tetrahydroquinoxalin-6-yl)-2-(4,5-dihydro-1H-imidazol-2-yl)hydrazine |
|---|---|
| Synonym | More Synonyms |
| Density | 1.84g/cm3 |
|---|---|
| Boiling Point | 420ºC at 760 mmHg |
| Molecular Formula | C11H15BrN6 |
| Molecular Weight | 311.18100 |
| Flash Point | 207.8ºC |
| Exact Mass | 310.05400 |
| PSA | 72.51000 |
| LogP | 1.66650 |
| Vapour Pressure | 2.92E-07mmHg at 25°C |
| Index of Refraction | 1.798 |
|
~85%
1-(5-bromo-1,2,... CAS#:134892-42-5 |
| Literature: Allergan, Inc. Patent: US5077292 A1, 1991 ; |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| 6-Quinoxalinamine,5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-1,2,3,4-tetrahydro |
| 5-bromo-6-(2-imidazolin-2-ylamino)-1,2,3,4-tetrahydroquinoxaline |